


Ask a doctor about a prescription for SUMATRIPTAN AUROVITAS 50 mg TABLETS
Package Leaflet: Information for the User
Sumatriptan Aurovitas 50 mg Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Sumatriptan belongs to a group of medicines called triptans (also known as 5-HT1 receptor agonists), which are used to treat migraine.
The symptoms of migraine can be caused by temporary widening of blood vessels in the head. It is thought that sumatriptan works by reversing this widening of blood vessels. This helps to relieve the headache and other symptoms of a migraine attack, such as feeling sick (nausea or vomiting) and being sensitive to light and sound.
Sumatriptan only works when a migraine attack has started. It does not prevent migraine attacks from happening.
Do not use sumatriptan to try to prevent an attack of migraine.
Do not take Sumatriptan Aurovitas
If you think you may have any of these problems, or if you are not sure, consult your doctor before taking sumatriptan.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Sumatriptan Aurovitas.
If you have any extra risk factors
In very rare cases, some people have developed serious heart problems after taking sumatriptan, even though they had no signs of heart disease before. If any of the above points apply to you, it may mean that you have a greater risk of developing heart disease, so:
? Tell your doctor to check your heart function before you are prescribed sumatriptan.
If you have a history of fits (seizures)
Or if you have other conditions which may make you more likely to have fits – for example, a head injury or alcoholism.
If you have liver or kidney disease
? Tell your doctor so that you can be monitored more closely.
If you are allergic to antibiotics called sulfonamides
If so, you may also be allergic to sumatriptan. If you know you are allergic to sulfonamide antibiotics but are not sure if this is the type you are allergic to:
? Tell your doctor or pharmacist before taking sumatriptan.
If you are taking antidepressants called SSRIs (selective serotonin reuptake inhibitors) or SNRIs (serotonin and noradrenaline reuptake inhibitors), tell your doctor or pharmacist before taking sumatriptan. See: Other medicines and Sumatriptan Aurovitas.
If you take sumatriptan frequently
Taking sumatriptan too often may make your headaches worse. Tell your doctor if this happens, your doctor may advise you to stop taking sumatriptan.
If you feel pain or tightness in your chest after taking sumatriptan
These effects may be intense but generally pass quickly. If they do not pass quickly, or get worse (especially chest pain), seek medical help immediately. The section 4 of this leaflet contains more information on these possible side effects.
Other medicines and Sumatriptan Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Some medicines must not be taken with sumatriptan and others may cause adverse effects if taken with sumatriptan. You must tell your doctor if you are taking:
Pregnancy, breast-feeding and fertility
Driving and using machines
Both the symptoms of migraine and the medicine may cause you to feel drowsy. If this happens, do not drive or use any tools or machines.
Sumatriptan may cause side effects such as dizziness and weakness that can affect your ability to react. Wait until you know how sumatriptan affects you before driving or using machines.
Sumatriptan Aurovitas contains sodium
This medicine contains less than 1 mmol sodium (23 mg) per tablet, which is essentially ‘sodium-free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is:
Adults:
The recommended dose is one 50 mg sumatriptan tablet for the treatment of a migraine attack. Some patients may need a 100 mg dose.
Use in children and adolescents (under 18 years)
Sumatriptan is not recommended for use in children and adolescents.
Use in elderly patients (over 65 years)
Sumatriptan is not recommended for use in this age group.
Use in patients with liver impairment
Your doctor may prescribe you a 50 mg sumatriptan dose.
Method of administration:
Swallow the tablet with water, preferably as soon as you feel the migraine attack starting. Do not crush or chew the tablets.
If you feel that the effect of sumatriptan is too strong or too weak, tell your doctor or pharmacist.
Duration of treatment:
If your symptoms do not improve after the first dose, do not take a second dose for the same attack. If you get another attack, you can take sumatriptan again.
If your symptoms improve but then come back, you can take a second or third dose, providing you leave at least 2 hours between doses.
Do not take more than 300 mg of sumatriptan in a 24-hour period.
Do not exceed the recommended dose.
If you take more Sumatriptan Aurovitas than you should
If you have taken more sumatriptan than you should, talk to your doctor or pharmacist or go to the nearest hospital casualty department immediately. Take the medicine pack with you. You may experience side effects such as those listed in “Possible side effects”.
If you forget to take Sumatriptan Aurovitas
Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Some of these symptoms may be caused by the migraine itself.
Although the following side effects are said to occur, their exact frequency is unknown.
If you notice any of these symptoms soon after taking sumatriptan:
? Do not take sumatriptan again. Contact your doctor immediately.
Common (affects up to 1 in 10 people)
Other common side effects include:
Very rare (affects up to 1 in 10,000 people)
Some people may experience any of the following side effects, but the frequency is not known
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency’s website: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice any visible signs of deterioration.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Composition of Sumatriptan Aurovitas
Appearance and packaging of the product
Sumatriptan Aurovitas 50 mg Tablets EFG are white or almost white, capsule-shaped, biconvex tablets, marked with “C” on one side and “33” on the other.
Sumatriptan Aurovitas 50 mg Tablets EFG are available in packs of 2, 3, 4, 6, 8, 12, 18, 20, 30, 50 or 100 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder and manufacturer
Marketing authorisation holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
This medicine is authorised in the Member States of the European Economic Area under the following names:
Germany: | Sumatriptan Aurobindo 50 mg Tabletten |
Netherlands: | Sumatriptan Aurobindo 50 mg tabletten |
Spain: | Sumatriptán Aurovitas 50 mg comprimidos EFG |
Sweden: | Sumatriptan Aurobindo 50 mg tabletter |
Date of last revision of this leaflet: December 2021
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es).
The average price of SUMATRIPTAN AUROVITAS 50 mg TABLETS in October, 2025 is around 12.18 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for SUMATRIPTAN AUROVITAS 50 mg TABLETS – subject to medical assessment and local rules.